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Abstract
A 54-year-old woman referred to a specialist unit for weight loss, lethargy, and a palpable pelvic mass.
Thought to have ovarian cancer metastasized to the kidney, underwent a left nephrectomy and para-
aortic clearance, with a total abdominal hysterectomy and bilateral salpingo-oophorectomy with
peritoneal biopsies. Histology proved it was actually a renal cell carcinoma metastasized to the
ovaries. During further follow ups she had developed bone and pulmonary metastasis and died
shortly after the diagnosis of metastasis. With only 14 reported cases in the literature increased
awareness would aid management of similar cases.
Introduction
Renal cell carcinoma, also called renal adenocarcinoma or
hypernephroma, is a common malignant solid tumour
which accounts for 75% of renal neoplasm and 3% of all
adult malignancies [1,2]. About 20-30% of patients have
distant metastasis during their first presentation, and 50%
develop metastasis during follow up [2,3]. RCC, has a 2:1
male to female ration with a mean age at presentation
between 50-70 years [2].
Case presentation
A 54-year-old Caucasian woman was referred to the gynaecol-
ogy outpatient department by her GP for a 3 month history
of lethargy, a 4 stone weight loss, and on examination a
non-tender left pelvic mass was palpated. An ultrasound
revealed a solid 4 cm mass in the left adnexa. Incidentally, the
ultrasound also revealed an enlarged left kidney, with a solid
mass occupying the middle and upper poles.
A CT scan revealed a 10 × 8 cm intensely enhancing
heterogeneous mass arising from the upper pole of the left
kidney, consistent with renal cell diagnosis (Figure 1).
There was spread to the left para-aortic region at the level
of the hilum, where a 1.5 cm lymph node was found. Also
the left adnexal region, close to the left lateral margin of
the uterus, revealed a 4 cm heterogeneous mass with fairly
intense enhancement, which was initially thought to be a
pedunculated fibroid (Figure 2).
Thought to be an ovarian tumour, which metastasised to
the kidney a joint gynaecological and urological opera-
tion was undertaken where she underwent a left
nephrectomy & para-aortic clearance, with a total
abdominal hysterectomy and bilateral salpingooophor-
ectomy with peritoneal biopsies. Bone scan and chest CT
showed no evidence of metastasis anywhere else in her
body.
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renal cell carcinoma of low grade and high grade
transformation with sarcomatoid features (Figure 3). The
grade was a grade 4 of Fuhrman’s Classification system for
nuclear grading. The report of the lymph node showed a
sarcomatoid high grade metastatic renal cell carcinoma.
The left ovary was entirely consistent with metastatic high
grade renal cell carcinoma (Figure 4).
She initially improved but 6 months after her operation
during a routine follow ups she complained of left
shoulder pain and further investigation found lytic lesions
in her left proximal humerus and multiple pulmonary
metastases. MDT decision was for further palliative radio-
therapy and therapy with zoledronate for symptomatic
relief. Unfortunately she died 3 months later.
Figure 1. Contrast CT scan of the Left Renal Cell Carcinoma
revealing a 10 × 8 cm intensely enhancing heterogeneous
mass arising from the upper pole.
Figure 2. Contrast CT scan of the Left Ovarian metastasis;
showing a 4 cm heterogeneous mass with fairly intense
enhancement.
Figure 3. Haematoxylin & Eosin stained section of kidney
tumour. Some parts are low grade clear cell (inset top right),
but most (main photo) is high grade with eosinophilic
cytoplasm, as were the metastases. Scale is 50 mu; low grade
and high grade transformation with sarcomatoid features.
Figure 4. Haematoxylin & Eosin stained section from ovarian
metastasis. Same pattern as high grade parts of kidney. Note
typical thin walled staghorn vessels, the large one containing
strands of fibrin; entirely consistent with metastatic high grade
renal cell carcinoma.
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Renal cell carcinoma most frequently metastasize via
lymphatic and venous routes to the lungs (50-60%),
lymph nodes (36%), bones (30-40%), liver (30-40%),
and brain (5%) [3]. RCC is known to metastasis to other
sites but these are rare occurrences.
The ovaries are a common site for intraabdominal
metastasis and about 6% of ovarian cancers found at
laparotomy are secondaries from other sites, commonly
stomach, colon, breast, and lymphoma [4]. However
ovarian metastasis from renal cell carcinoma is rare. This
may be due to the fact that RCC predominates in males;
also the mean age group in which RCC presents are of
postmenopausal women where the ovaries have under-
gone vascular sclerosis [5]. More over some metastatic
lesions are mistaken for primary ovarian tumours [5].
In one autopsy study, ovarian metastasis was found in
0.5% of cases of RCC [6]. Metastasis to ovaries is thought
to occur by retrograde venous embolisation through the
renal vein to the ovarian vessels [5,6]. Metastasis through
this mechanism exploits the unique anatomy of the left
renal and ovarian veins. It mandates incompetent gonadal
veins to allow for retrograde venous flow. In fact, two
thirds of reported cases arose from a left sided lesion. Thus,
it appears that the hallmark for the renal-ovarian axis is its
unique venous anatomy.
Only 14 such cases are reported in literature. Out of these,
13 cases were metastasis of RCC of clear cell type and1 was
from a renal pelvis transitional cell carcinoma. Five of
these cases were diagnosed as primary ovarian clear cell
cancer, whilst renal primary was diagnosed only after
proper investigations.
Histological differentiation between clear RCC and
Ovarian Clear cell cancer may be difficult. However,
certain histological and ultra structural features may help
to establish the correct diagnosis. The presence of clear
cells with some areas showing a tubulocystic pattern with
the characteristic “hob-nail” appearance of the lining
epithelium and extra cellular mucin are more typical of
clear cell carcinoma of the ovary [7-9]. While clear RCC
are roundto ovoidand circumscribedbya psuedocapsule
of compressed parenchyma and fibrous tissue, rather
than a true capsule, they are also hypervascular [10].
The cells also contain numerous lipid vacuoles and
long slender microvilli and lack rough endoplasmic
reticulum [7-9].
In the ovary the differential diagnosis of clear cell
neoplasm includes primary clear cell carcinoma, steroid
cell tumour, and dysgerminoma. While metastatic RCC
may mimic these entities. Rarely Lipoid cell tumours,
Hilus cell and Leydig cell tumours may also be mistaken
for metastatic RCC.
However, careful gross and microscopic examination
combined with immunohistochemical analyses can aid
in the distinction of this metastatic lesion. Tumour
markers are another way of differentiating between renal
and ovarian clear cell carcinomas. Monoclonal antibodies
and are expressed in 80-90% of renal cell tumours but its
specificity as a diagnostic marker is still not established.
Cytokeratin 7 is expressed in most ovarian cell carcinomas
while negative in RCC [8]. CA125 is another marker
expressed by epithelial ovarian tumours including clear
cell carcinomas but also negative in RCC [8].
Recent studies have shown that systematic therapy can
improve survival rates in patients with recurrent metastatic
RCC [11]. An increased understanding of RCC molecular
biology has lead to the production of vascular endothelial
growth factor (VEGF) and mammalian target of rapamycin
(mTOR) inhibiting drugs, which inhibit those biological
pathways which the tumour cells rely on for growth [11].
VEGF inhibting drugs such as sunitinib, sorafenib, and
bevacizumab, and mTOR inhibiting drugs like temsiroli-
mus, have shown some positive results in the increased
progression free survival rates [11]. Recent advancements
in the treatment of metastatic RCC give numerous
management options each with risks and benefits, but
with limitations in the data available [11]. There are
ongoing studies investigating the risks and benefits of
combination of these treatments with the over all aim of
maximizing the overall therapeutic benefit and delay the
lethal burden of the disease, while improving the quality
of life of the patient [11].
After a thorough review of Medline, Pubmed, and the
internet, our case represents only the fifteenth reported
case of renal cell carcinoma metastasised to the ovary. In
addition, it is unique in its presentation in which
symptoms of weight loss, lethargy, and loss of appetite
started only 3 months prior to her referral.
Conclusions
Women presenting with an ovarian malignancy may be
misdiagnosed. Full abdominal imaging should be per-
formed before exploration. In this review, a delay in
diagnosisoftheprimarylesionfromthekidneyoccurredin
over one third of cases, with the presenting symptoms
correspondingtothemetastaticsiteratherthantheprimary
lesion.Limited evidencesuggestthatsurgicalextirpationof
both lesions may lead to long term disease free survival.
Although rare, possibility of ovarian metastasis from renal
cell carcinoma should be considered in the differential
diagnosis. It is important to identify the primary site by
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course of therapy varies in addition to the prognostic
implications. Thus, timely diagnosis of the primary lesions
must be pursued.
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